loading page

CD39 identifies a specific CD8+T cell population in EGFR-driven lung adenocarcinoma related metastatic pleural effusion.
  • +4
  • Lei-lei Lv,
  • Hong Wang,
  • Yao Zhang,
  • Jia Zhai,
  • Yu Shen,
  • Qiu Qu,
  • Cheng Chen
Lei-lei Lv
First Affiliated Hospital of Soochow University
Author Profile
Hong Wang
First Affiliated Hospital of Soochow University
Author Profile
Yao Zhang
First Affiliated Hospital of Soochow University
Author Profile
Jia Zhai
First Affiliated Hospital of Soochow University
Author Profile
Yu Shen
First Affiliated Hospital of Soochow University
Author Profile
Qiu Qu
First Affiliated Hospital of Soochow University
Author Profile
Cheng Chen
First Affiliated Hospital of Soochow University

Corresponding Author:[email protected]

Author Profile

Abstract

Malignant pleural effusions (MPE) are common in lung cancer, which were a complex microenvironment containing a plethora of immune and tumor signals. Gene alterations such as driver gene mutations were considered to affect the components in the TIME of NSCLC. Here, we demonstrated that pleural CD39+CD8+T cells were selectively elevated in firstly-diagnosed lung adenocarcinoma with wild-type EGFR compared to that in mutant EGFR, while abnormally more represented in MPE with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) acquired resistance. Analysis showed that pleural CD39+CD8+T cells display exhausted phenotype and potential cytolytic function, together with skewed usages of T cell receptor (TCR)-Vβ repertoire in comparison with CD39-CD8+T cells, which constituted common feature of lung adenocarcinoma related MPE. Further study revealed TCR-Vβ diversity tended to be more enhanced in pleural CD39+CD8+T cell from MPE coupled with EGFR-TKI acquired resistance. Taken together, we have identified a subset of CD8+T cells expressing CD39 in MPE, whom proposed as the potential tumor-reactive CD8+T cells, and further provided a new understanding of dynamic immune composition of EGFR-mutant tumor microenvironment.